1-(2-(decylthio)ethyl)azacyclopentane-2-one has been researched along with betadex in 1 studies
| Studies (1-(2-(decylthio)ethyl)azacyclopentane-2-one) | Trials (1-(2-(decylthio)ethyl)azacyclopentane-2-one) | Recent Studies (post-2010) (1-(2-(decylthio)ethyl)azacyclopentane-2-one) | Studies (betadex) | Trials (betadex) | Recent Studies (post-2010) (betadex) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 8,785 | 97 | 4,452 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Irie, T; Noda, K; Saita, M; Uekama, K; Yano, T | 1 |
1 other study(ies) available for 1-(2-(decylthio)ethyl)azacyclopentane-2-one and betadex
| Article | Year |
|---|---|
Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
Topics: Administration, Cutaneous; Alprostadil; Animals; Azepines; beta-Cyclodextrins; Cyclodextrins; Drug Carriers; Female; Mice; Mice, Hairless; Ointments; Pyrroles; Regional Blood Flow; Skin; Skin Absorption | 1992 |